Quick Answer
60 DEGREES PHARMACEUTICALS, INC. reported Operating Income Loss of -$7.76 million for the year ending 2025.
- 60 DEGREES PHARMACEUTICALS, INC. showed an increase of +20.1% in Operating Income Loss from 2024 to 2025.
- This data is from 60 DEGREES PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), 60 DEGREES PHARMACEUTICALS, INC.'s Operating Income Loss has declined by 343.2%.
- Historical annual values: Fiscal year 2025: -$7.76 million | Fiscal year 2024: -$9.72 million | Fiscal year 2023: -$5.15 million | Fiscal year 2022: -$1.75 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: